financetom
Business
financetom
/
Business
/
RIL AGM: Jio Institute to begin operations this year, says Nita Ambani
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RIL AGM: Jio Institute to begin operations this year, says Nita Ambani
Jun 24, 2021 6:00 AM

Reliance Foundation’s proposed multidisciplinary university, Jio Institute will begin operations this year.

Share Market Live

NSE

Nita Ambani, founder and chairperson, Reliance Foundation announced,

"despite the pandemic, I am pleased to announce that Jio Institute is all set to commence academic sessions at their campus in Navi Mumbai this year itself," at the 44th annual general meeting (AGM) of Reliance Industries (RIL).

"We have worked very hard through these challenging times, to bring our dream project – the Jio Institute – to life! Jio Institute is envisioned to be an exemplary academic institution with a world-class platform for research, innovation, and lifelong learning. It will prepare the next generation of global leaders who will significantly contribute to the advancement of India and the world," she added.

#RILAGM | 'Pleased to announce that Jio Institute is all set to commence academic sessions at their campus in Navi Mumbai this year itself,' Nita Ambani says at the 44th #RelianceAGM pic.twitter.com/0hBHUdGF58

— CNBC-TV18 (@CNBCTV18Live) June 24, 2021

Jio Institute was declared an Institute of Eminence (IoE) by the Narendra Modi government. It was awarded the IoE status in 2018 under the ‘Greenfield’ category, meant for new or proposed institutions that are yet to come into existence.

It was given a letter of intent at the time and was given time until July 2021 to establish itself and submit a readiness report to the government.

Catch live updates from the AGM here

(Disclosure: Reliance Industries Ltd, which owns Jio, is the sole beneficiary of Independent Media Trust that controls Network18, the parent company of CNBCTV18.com.)

First Published:Jun 24, 2021 3:00 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
UK regulator investigates five companies for fake reviews and misleading ratings
UK regulator investigates five companies for fake reviews and misleading ratings
Mar 27, 2026
March 27 (Reuters) - The British competition regulator on Friday said it is investigating five companies including, Autotrader and Just Eat, as part of its crackdown on fake reviews and misleading star ratings. ...
Chinese universities with military links bought Super Micro servers with restricted AI chips
Chinese universities with military links bought Super Micro servers with restricted AI chips
Mar 26, 2026
BEIJING, March 27 (Reuters) - Four Chinese universities, including two linked to the People's Liberation Army, bought Super Micro Computer ( SMCI ) servers with restricted AI chips over the past year, procurement data shows, even as the U.S. clamps down on sales of some advanced processors to China. It was not clear how the servers were sourced. Concerned about...
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
Mar 26, 2026
– Acquisition brings together Excellergy's differentiated trifunctional allergic effector cell response inhibitors (ECRIs) and the development expertise of Novartis, with a total potential transaction value of up to $2 billion – – Exl-111 is a potentially first-in-class allergic trifunctional ECRI targeting the IgE axis and is currently in Phase 1 development – PALO ALTO, Calif., March 27, 2026 (GLOBE NEWSWIRE)...
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
Mar 26, 2026
March 27 (Reuters) - Swiss pharma company Novartis said on Friday it will acquire California-based biotech company Excellergy in a deal worth up to $2 billion. Under the agreement, Novartis said it would pay up to $2 billion in upfront and milestone payments. The transaction is expected to close in the second half of 2026, subject to customary conditions, including...
Copyright 2023-2026 - www.financetom.com All Rights Reserved